ðÿ €\þ´ú¯ß..¼¡– Idñ b d ¶f :$l0Å}˾ KA ”á¡$F º î ý!ÏåYB UÕ½›‰9> Äèä 'g Q FVÓ(õ´ µñ >øˆW. ÅAŠšùĶd Ìô 8rGOû ö ...

Fewer children have gotten a flu shot this season while adult vaccination rates have remained steady, according to data from the Centers for Disease Control and Prevention. According to the CDC, 36.6% ...

The FDA will continue to evaluate whether to authorize the potential use of a second booster dose in other age groups. “The FDA has determined that the known and potential benefits of a second ...

Additionally, in real-world evidence studies they have demonstrated significant and consistent reductions in flu-related hospitalizations. The Novavax Covid-19 vaccine has been shown to have a better ...

Sanofi has announced that its two combination vaccine candidates for COVID-19 and influenza (flu) have been granted fast track designation by the US Food and Drug Administration (FDA) for use in ...

Sanofi has announced that its two combination vaccine candidates, designed to prevent both influenza and Covid-19 infections in people aged 50 years and above, have received fast track designation ...

The FDA has placed a hold on all clinical studies of vaccines for respiratory syncytial virus in infants due to safety concerns following a trial involving two mRNA-based vaccine candidates from ...

Sanofi SNY announced that the FDA has granted ... and Flublok flu vaccines. Novavax recently signed a multi-billion dollar deal with Sanofi for its protein-based COVID-19 vaccine.

With just over a week left to book COVID-19 and flu vaccinations online ... including those working in care homes for older adults In addition to the above, those also eligible for a flu vaccine ...

Novavax NVAX announced that it has started dosing participants in the phase III study evaluating its experimental COVID-19-influenza combination (CIC) and stand-alone influenza vaccine candidates.

The first combination vaccine candidate (NCT06695117) consists of the influenza protein-based trivalent vaccine Fluzone High-Dose combined with the adjuvanted recombinant Novavax COVID-19 vaccine. The ...

Sanofi gets FDA Fast Track designation for two combination vaccine candidates to prevent influenza and COVID-19 infections in individuals 50 years of age and older, according to statement. Both ...